#begin document (en_4138.txt); part 000
en_4138.txt	0	0	The	DT	(TOP(NP*	-	-	-	-	*	-
en_4138.txt	0	1	Paracetamol	NNP	*	-	-	-	-	*	-
en_4138.txt	0	2	Dilemma	NNP	*))	-	-	-	-	*	-

en_4138.txt	0	0	WELLINGTON	NNP	(TOP(S(S(NP(NP*	-	-	-	-	*	(0
en_4138.txt	0	1	â€“	NNP	*	-	-	-	-	*	-
en_4138.txt	0	2	Paracetamol	NNP	*)	-	-	-	-	*	-
en_4138.txt	0	3	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_4138.txt	0	4	known	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	5	as	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	6	acetaminophen	NN	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	7	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	8	the	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	9	United	NNP	*	-	-	-	-	*	-
en_4138.txt	0	10	States	NNPS	*)))))	-	-	-	-	*	-
en_4138.txt	0	11	-RRB-	-RRB-	*))	-	-	-	-	*	0)
en_4138.txt	0	12	is	VBZ	(VP*	-	-	-	-	*	-
en_4138.txt	0	13	one	CD	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	14	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	15	the	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	16	world	NN	*)))))	-	-	-	-	*	-
en_4138.txt	0	17	'	:	*	-	-	-	-	*	-
en_4138.txt	0	18	s	PRP	(S(NP*)	-	-	-	-	*	-
en_4138.txt	0	19	most	RBS	(ADVP*	-	-	-	-	*	-
en_4138.txt	0	20	commonly	RB	*)	-	-	-	-	*	-
en_4138.txt	0	21	used	VBD	(VP*	-	-	-	-	*	-
en_4138.txt	0	22	drugs	NNS	(NP*)))	-	-	-	-	*	-
en_4138.txt	0	23	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	It	PRP	(TOP(S(NP*)	-	-	-	-	*	(1)
en_4138.txt	0	1	is	VBZ	(VP*	-	-	-	-	*	-
en_4138.txt	0	2	the	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	3	preferred	VBN	*	-	-	-	-	*	-
en_4138.txt	0	4	medication	NN	*)	-	-	-	-	*	-
en_4138.txt	0	5	for	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	6	relieving	VBG	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	7	fever	NN	(NP*	-	-	-	-	*	-
en_4138.txt	0	8	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	9	pain	NN	*)	-	-	-	-	*	-
en_4138.txt	0	10	because	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	11	of	IN	*	-	-	-	-	*	-
en_4138.txt	0	12	its	PRP$	(NP*	-	-	-	-	*	(1)
en_4138.txt	0	13	safety	NN	*	-	-	-	-	*	-
en_4138.txt	0	14	profile	NN	*)))))))	-	-	-	-	*	-
en_4138.txt	0	15	.	.	*	-	-	-	-	*	-
en_4138.txt	0	16	However	RB	(S(ADVP*)	-	-	-	-	*	-
en_4138.txt	0	17	,	,	*	-	-	-	-	*	-
en_4138.txt	0	18	10	CD	(ADVP(NP*	-	-	-	-	*	-
en_4138.txt	0	19	years	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	20	ago	RB	*)	-	-	-	-	*	-
en_4138.txt	0	21	,	,	*	-	-	-	-	*	-
en_4138.txt	0	22	a	DT	(NP*	-	-	-	-	*	(2
en_4138.txt	0	23	hypothesis	NN	*)	-	-	-	-	*	2)
en_4138.txt	0	24	was	VBD	(VP*	-	-	-	-	*	-
en_4138.txt	0	25	proposed	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	26	that	IN	(SBAR*	-	-	-	-	*	-
en_4138.txt	0	27	the	DT	(S(NP(NP*	-	-	-	-	*	(3
en_4138.txt	0	28	use	NN	*)	-	-	-	-	*	-
en_4138.txt	0	29	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	30	paracetamol	NN	(NP*)))	-	-	-	-	*	3)
en_4138.txt	0	31	may	MD	(VP*	-	-	-	-	*	-
en_4138.txt	0	32	increase	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	33	the	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	34	risk	NN	*)	-	-	-	-	*	-
en_4138.txt	0	35	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	36	developing	VBG	(NP*	-	-	-	-	*	-
en_4138.txt	0	37	asthma	NN	*))))))))))	-	-	-	-	*	-
en_4138.txt	0	38	.	.	*	-	-	-	-	*	-
en_4138.txt	0	39	It	PRP	(S(NP*)	-	-	-	-	*	(2)
en_4138.txt	0	40	was	VBD	(VP*	-	-	-	-	*	-
en_4138.txt	0	41	suggested	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	42	that	IN	(SBAR*	-	-	-	-	*	-
en_4138.txt	0	43	a	DT	(S(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	44	change	NN	*)	-	-	-	-	*	-
en_4138.txt	0	45	from	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	46	the	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	47	use	NN	*)	-	-	-	-	*	-
en_4138.txt	0	48	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	49	aspirin	NN	(NP*))))	-	-	-	-	*	-
en_4138.txt	0	50	to	TO	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	51	paracetamol	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	52	among	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	53	children	NNS	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	54	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	55	the	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	56	US	NNP	*))	-	-	-	-	*	-
en_4138.txt	0	57	during	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	58	the	DT	(NP(NP*	-	-	-	-	*	(4
en_4138.txt	0	59	1980	CD	*	-	-	-	-	*	-
en_4138.txt	0	60	'	POS	*)	-	-	-	-	*	-
en_4138.txt	0	61	s	NN	*))))))))	-	-	-	-	*	4)
en_4138.txt	0	62	may	MD	(VP*	-	-	-	-	*	-
en_4138.txt	0	63	have	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	64	contributed	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	65	to	TO	(PP*	-	-	-	-	*	-
en_4138.txt	0	66	the	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	67	increasing	VBG	*	-	-	-	-	*	-
en_4138.txt	0	68	prevalence	NN	*)	-	-	-	-	*	-
en_4138.txt	0	69	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	70	childhood	NN	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	71	asthma	NN	*)	-	-	-	-	*	-
en_4138.txt	0	72	noted	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	73	during	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	74	this	DT	(NP*	-	-	-	-	*	(4
en_4138.txt	0	75	period	NN	*)))))))))))))))	-	-	-	-	*	4)
en_4138.txt	0	76	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	Substitution	NN	(TOP(S(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	1	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	2	paracetamol	NN	(NP*))	-	-	-	-	*	-
en_4138.txt	0	3	for	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	4	aspirin	NN	(NP*)))	-	-	-	-	*	-
en_4138.txt	0	5	,	,	(PRN*	-	-	-	-	*	-
en_4138.txt	0	6	researchers	NNS	(S(NP*)	-	-	-	-	*	-
en_4138.txt	0	7	proposed	VBD	(VP*))	-	-	-	-	*	-
en_4138.txt	0	8	,	,	*)	-	-	-	-	*	-
en_4138.txt	0	9	may	MD	(VP*	-	-	-	-	*	-
en_4138.txt	0	10	have	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	11	led	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	12	to	TO	(PP*	-	-	-	-	*	-
en_4138.txt	0	13	an	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	14	enhanced	JJ	*	-	-	-	-	*	-
en_4138.txt	0	15	allergic	JJ	*	-	-	-	-	*	-
en_4138.txt	0	16	immune	JJ	*	-	-	-	-	*	-
en_4138.txt	0	17	response	NN	*))	-	-	-	-	*	-
en_4138.txt	0	18	,	,	*	-	-	-	-	*	-
en_4138.txt	0	19	thereby	RB	(S(ADVP*)	-	-	-	-	*	-
en_4138.txt	0	20	increasing	VBG	(VP*	-	-	-	-	*	-
en_4138.txt	0	21	susceptibility	NN	(NP*)	-	-	-	-	*	-
en_4138.txt	0	22	to	TO	(PP*	-	-	-	-	*	-
en_4138.txt	0	23	asthma	NN	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	24	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	25	other	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	26	allergic	JJ	*	-	-	-	-	*	-
en_4138.txt	0	27	disorders	NNS	*))))))))	-	-	-	-	*	-
en_4138.txt	0	28	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	Since	IN	(TOP(S(PP*	-	-	-	-	*	-
en_4138.txt	0	1	then	RB	(NP*))	-	-	-	-	*	-
en_4138.txt	0	2	,	,	*	-	-	-	-	*	-
en_4138.txt	0	3	a	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	4	number	NN	*)	-	-	-	-	*	-
en_4138.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	6	epidemiological	JJ	(NP*	-	-	-	-	*	(5
en_4138.txt	0	7	studies	NNS	*)))	-	-	-	-	*	5)
en_4138.txt	0	8	have	VBP	(VP*	-	-	-	-	*	-
en_4138.txt	0	9	reported	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	10	an	DT	(NP(NP*	-	-	-	-	*	(6
en_4138.txt	0	11	association	NN	*)	-	-	-	-	*	-
en_4138.txt	0	12	between	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	13	asthma	NN	(NP*	-	-	-	-	*	-
en_4138.txt	0	14	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	15	exposure	NN	*))	-	-	-	-	*	-
en_4138.txt	0	16	to	TO	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	17	paracetamol	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	18	in	IN	(PP(PP*	-	-	-	-	*	-
en_4138.txt	0	19	the	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	20	womb	NN	*))	-	-	-	-	*	-
en_4138.txt	0	21	,	,	*	-	-	-	-	*	-
en_4138.txt	0	22	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	23	childhood	NN	(NP*))	-	-	-	-	*	-
en_4138.txt	0	24	,	,	*	-	-	-	-	*	-
en_4138.txt	0	25	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	26	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	27	adulthood	NN	(NP*)))))))))	-	-	-	-	*	6)
en_4138.txt	0	28	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	These	DT	(TOP(S(NP*	-	-	-	-	*	(5
en_4138.txt	0	1	studies	NNS	*)	-	-	-	-	*	5)
en_4138.txt	0	2	led	VBD	(VP*	-	-	-	-	*	-
en_4138.txt	0	3	to	TO	(PP*	-	-	-	-	*	-
en_4138.txt	0	4	the	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	5	suggestion	NN	*	-	-	-	-	*	-
en_4138.txt	0	6	that	IN	(SBAR*	-	-	-	-	*	-
en_4138.txt	0	7	the	DT	(S(NP(NP*	-	-	-	-	*	(3
en_4138.txt	0	8	use	NN	*)	-	-	-	-	*	-
en_4138.txt	0	9	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	10	paracetamol	NN	(NP*)))	-	-	-	-	*	3)
en_4138.txt	0	11	may	MD	(VP*	-	-	-	-	*	-
en_4138.txt	0	12	represent	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	13	an	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	14	important	JJ	*	-	-	-	-	*	-
en_4138.txt	0	15	risk	NN	*	-	-	-	-	*	-
en_4138.txt	0	16	factor	NN	*)	-	-	-	-	*	-
en_4138.txt	0	17	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	18	the	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	19	development	NN	*)	-	-	-	-	*	-
en_4138.txt	0	20	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	21	asthma	NN	(NP*))))))))))))	-	-	-	-	*	-
en_4138.txt	0	22	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	1	latest	JJS	*	-	-	-	-	*	-
en_4138.txt	0	2	evidence	NN	*)	-	-	-	-	*	-
en_4138.txt	0	3	to	TO	(SBAR(S(VP*	-	-	-	-	*	-
en_4138.txt	0	4	support	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	5	this	DT	(NP*	-	-	-	-	*	(2
en_4138.txt	0	6	hypothesis	NN	*))))))	-	-	-	-	*	2)
en_4138.txt	0	7	comes	VBZ	(VP*	-	-	-	-	*	-
en_4138.txt	0	8	from	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	9	a	DT	(NP(NP*	-	-	-	-	*	(7
en_4138.txt	0	10	large	JJ	*	-	-	-	-	*	-
en_4138.txt	0	11	international	JJ	*	-	-	-	-	*	-
en_4138.txt	0	12	epidemiological	JJ	*	-	-	-	-	*	-
en_4138.txt	0	13	study	NN	*)	-	-	-	-	*	-
en_4138.txt	0	14	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	15	childhood	NN	(NP*	-	-	-	-	*	-
en_4138.txt	0	16	asthma	NN	*))	-	-	-	-	*	-
en_4138.txt	0	17	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_4138.txt	0	18	was	VBD	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	19	recently	RB	(ADVP*)	-	-	-	-	*	-
en_4138.txt	0	20	published	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	21	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	22	the	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	23	medical	JJ	*	-	-	-	-	*	-
en_4138.txt	0	24	journal	NN	*)	-	-	-	-	*	-
en_4138.txt	0	25	The	NNP	(NP*	-	-	-	-	*	-
en_4138.txt	0	26	Lancet	NNP	*))))))))))	-	-	-	-	*	7)
en_4138.txt	0	27	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	This	DT	(TOP(S(NP*	-	-	-	-	*	-
en_4138.txt	0	1	analysis	NN	*)	-	-	-	-	*	-
en_4138.txt	0	2	,	,	*	-	-	-	-	*	-
en_4138.txt	0	3	from	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	4	the	DT	(NP(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	5	International	NNP	*	-	-	-	-	*	-
en_4138.txt	0	6	Study	NNP	*)	-	-	-	-	*	-
en_4138.txt	0	7	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	8	Asthma	NNP	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	9	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	10	Allergies	NNP	*)	-	-	-	-	*	-
en_4138.txt	0	11	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	12	Childhood	NNP	(NP*)))))	-	-	-	-	*	-
en_4138.txt	0	13	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_4138.txt	0	14	ISAAC	NNP	(NP*)	-	-	-	-	*	-
en_4138.txt	0	15	-RRB-	-RRB-	*)))	-	-	-	-	*	-
en_4138.txt	0	16	,	,	*	-	-	-	-	*	-
en_4138.txt	0	17	involved	VBD	(VP*	-	-	-	-	*	-
en_4138.txt	0	18	more	JJR	(NP(NP(QP*	-	-	-	-	*	(8
en_4138.txt	0	19	than	IN	*	-	-	-	-	*	-
en_4138.txt	0	20	200,000	CD	*)	-	-	-	-	*	-
en_4138.txt	0	21	six-	JJ	(ADJP*	-	-	-	-	*	-
en_4138.txt	0	22	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	23	seven-year-old	JJ	*)	-	-	-	-	*	-
en_4138.txt	0	24	children	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	25	from	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	26	73	CD	(NP*	-	-	-	-	*	-
en_4138.txt	0	27	centers	NNS	*))	-	-	-	-	*	-
en_4138.txt	0	28	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	29	31	CD	(NP*	-	-	-	-	*	-
en_4138.txt	0	30	countries	NNS	*))))	-	-	-	-	*	8)
en_4138.txt	0	31	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	(8
en_4138.txt	0	1	children	NNS	*	-	-	-	-	*	-
en_4138.txt	0	2	'	POS	*)	-	-	-	-	*	8)
en_4138.txt	0	3	s	JJ	*	-	-	-	-	*	-
en_4138.txt	0	4	parents	NNS	*	-	-	-	-	*	-
en_4138.txt	0	5	or	CC	*	-	-	-	-	*	-
en_4138.txt	0	6	guardians	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	7	completed	VBD	(VP*	-	-	-	-	*	-
en_4138.txt	0	8	written	JJ	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	9	questionnaires	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	10	about	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	11	current	JJ	(NP(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	12	symptoms	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	13	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	14	asthma	NN	(NP*)))	-	-	-	-	*	-
en_4138.txt	0	15	,	,	*	-	-	-	-	*	-
en_4138.txt	0	16	rhinitis	NN	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	17	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_4138.txt	0	18	hayfever	JJR	*	-	-	-	-	*	-
en_4138.txt	0	19	-RRB-	-RRB-	*))	-	-	-	-	*	-
en_4138.txt	0	20	,	,	*	-	-	-	-	*	-
en_4138.txt	0	21	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	22	eczema	NN	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	23	,	,	*	-	-	-	-	*	-
en_4138.txt	0	24	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	25	about	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	26	several	JJ	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	27	risk	NN	*	-	-	-	-	*	-
en_4138.txt	0	28	factors	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	29	,	,	*	-	-	-	-	*	-
en_4138.txt	0	30	including	VBG	(PP*	-	-	-	-	*	-
en_4138.txt	0	31	use	NN	(NP(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	32	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	33	paracetamol	NN	(NP*))	-	-	-	-	*	-
en_4138.txt	0	34	for	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	35	fever	NN	(NP*))	-	-	-	-	*	-
en_4138.txt	0	36	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	37	the	DT	(NP(NP(NP*	-	-	-	-	*	(7
en_4138.txt	0	38	child	NN	*	-	-	-	-	*	-
en_4138.txt	0	39	'	POS	*)	-	-	-	-	*	7)
en_4138.txt	0	40	s	VBG	*	-	-	-	-	*	-
en_4138.txt	0	41	first	JJ	*	-	-	-	-	*	-
en_4138.txt	0	42	year	NN	*)	-	-	-	-	*	-
en_4138.txt	0	43	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	44	life	NN	(NP*)))))	-	-	-	-	*	-
en_4138.txt	0	45	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	46	frequency	NN	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	47	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	48	paracetamol	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	49	use	NN	*)))))))))))	-	-	-	-	*	-
en_4138.txt	0	50	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	51	the	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	52	past	JJ	*	-	-	-	-	*	-
en_4138.txt	0	53	12	CD	*	-	-	-	-	*	-
en_4138.txt	0	54	months	NNS	*)))	-	-	-	-	*	-
en_4138.txt	0	55	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	(7
en_4138.txt	0	1	study	NN	*)	-	-	-	-	*	7)
en_4138.txt	0	2	identified	VBD	(VP*	-	-	-	-	*	-
en_4138.txt	0	3	that	IN	(SBAR*	-	-	-	-	*	-
en_4138.txt	0	4	the	DT	(S(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	5	reported	JJ	*	-	-	-	-	*	-
en_4138.txt	0	6	use	NN	*)	-	-	-	-	*	-
en_4138.txt	0	7	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	8	paracetamol	NN	(NP*))	-	-	-	-	*	-
en_4138.txt	0	9	for	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	10	fever	NN	(NP*))	-	-	-	-	*	-
en_4138.txt	0	11	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	12	the	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	13	first	JJ	*	-	-	-	-	*	-
en_4138.txt	0	14	year	NN	*)	-	-	-	-	*	-
en_4138.txt	0	15	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	16	life	NN	(NP*)))))	-	-	-	-	*	-
en_4138.txt	0	17	was	VBD	(VP*	-	-	-	-	*	-
en_4138.txt	0	18	associated	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	19	with	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	20	symptoms	NNS	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	21	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	22	asthma	NN	(NP*))	-	-	-	-	*	-
en_4138.txt	0	23	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	24	the	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	25	six-	JJ	(ADJP*	-	-	-	-	*	-
en_4138.txt	0	26	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	27	seven-year-old	JJ	*)	-	-	-	-	*	-
en_4138.txt	0	28	children	NNS	*)))))))))	-	-	-	-	*	-
en_4138.txt	0	29	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	(6
en_4138.txt	0	1	association	NN	*)	-	-	-	-	*	6)
en_4138.txt	0	2	was	VBD	(VP*	-	-	-	-	*	-
en_4138.txt	0	3	present	JJ	(ADJP*)	-	-	-	-	*	-
en_4138.txt	0	4	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	5	all	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	6	major	JJ	*	-	-	-	-	*	-
en_4138.txt	0	7	regions	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	8	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	9	the	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	10	world	NN	*))))	-	-	-	-	*	-
en_4138.txt	0	11	,	,	*	-	-	-	-	*	-
en_4138.txt	0	12	with	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	13	an	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	14	estimated	VBN	*	-	-	-	-	*	-
en_4138.txt	0	15	46	CD	(ADJP*	-	-	-	-	*	-
en_4138.txt	0	16	%	NN	*)	-	-	-	-	*	-
en_4138.txt	0	17	increased	VBN	*	-	-	-	-	*	-
en_4138.txt	0	18	risk	NN	*)	-	-	-	-	*	-
en_4138.txt	0	19	following	VBG	(PP*	-	-	-	-	*	-
en_4138.txt	0	20	adjustment	NN	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	21	for	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	22	other	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	23	risk	NN	*	-	-	-	-	*	-
en_4138.txt	0	24	factors	NNS	*)))))))	-	-	-	-	*	-
en_4138.txt	0	25	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	A	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	1	dose-dependent	JJ	*	-	-	-	-	*	-
en_4138.txt	0	2	association	NN	*)	-	-	-	-	*	-
en_4138.txt	0	3	between	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	4	asthma	NN	(NP(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	5	symptoms	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	6	at	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	7	6-7	CD	(NP*	-	-	-	-	*	-
en_4138.txt	0	8	years	NNS	*)))	-	-	-	-	*	-
en_4138.txt	0	9	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	10	paracetamol	JJ	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	11	use	NN	*)	-	-	-	-	*	-
en_4138.txt	0	12	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	13	the	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	14	previous	JJ	*	-	-	-	-	*	-
en_4138.txt	0	15	12	CD	*	-	-	-	-	*	-
en_4138.txt	0	16	months	NNS	*))))))	-	-	-	-	*	-
en_4138.txt	0	17	was	VBD	(VP*	-	-	-	-	*	-
en_4138.txt	0	18	also	RB	(ADVP*)	-	-	-	-	*	-
en_4138.txt	0	19	observed	VBN	(VP*))	-	-	-	-	*	-
en_4138.txt	0	20	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	Similar	JJ	(TOP(S(NP*	-	-	-	-	*	-
en_4138.txt	0	1	associations	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	2	were	VBD	(VP*	-	-	-	-	*	-
en_4138.txt	0	3	observed	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	4	between	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	5	the	DT	(NP(NP(NP*	-	-	-	-	*	(3
en_4138.txt	0	6	use	NN	*)	-	-	-	-	*	-
en_4138.txt	0	7	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	8	paracetamol	NN	(NP*)))	-	-	-	-	*	3)
en_4138.txt	0	9	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	10	the	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	11	risk	NN	*)	-	-	-	-	*	-
en_4138.txt	0	12	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	13	severe	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	14	asthma	NN	*	-	-	-	-	*	-
en_4138.txt	0	15	symptoms	NNS	*)))))))	-	-	-	-	*	-
en_4138.txt	0	16	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	1	proportion	NN	*)	-	-	-	-	*	-
en_4138.txt	0	2	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	3	asthma	NN	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	4	cases	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	5	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_4138.txt	0	6	could	MD	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	7	be	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	8	attributed	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	9	to	TO	(PP*	-	-	-	-	*	-
en_4138.txt	0	10	exposure	NN	(NP*	-	-	-	-	*	-
en_4138.txt	0	11	to	TO	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	12	paracetamol	VB	(VP*)))))))))))))	-	-	-	-	*	-
en_4138.txt	0	13	was	VBD	(VP*	-	-	-	-	*	-
en_4138.txt	0	14	calculated	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	15	to	TO	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	16	be	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	17	between	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	18	22	CD	(NP(QP*	-	-	-	-	*	-
en_4138.txt	0	19	%	NN	*	-	-	-	-	*	-
en_4138.txt	0	20	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	21	38	CD	*	-	-	-	-	*	-
en_4138.txt	0	22	%	NN	*))))))))	-	-	-	-	*	-
en_4138.txt	0	23	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	Paracetamol	JJ	(TOP(S(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	1	use	NN	*)	-	-	-	-	*	-
en_4138.txt	0	2	both	DT	(PP*	-	-	-	-	*	-
en_4138.txt	0	3	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	4	the	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	5	first	JJ	*	-	-	-	-	*	-
en_4138.txt	0	6	year	NN	*)	-	-	-	-	*	-
en_4138.txt	0	7	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	8	life	NN	(NP*))))	-	-	-	-	*	-
en_4138.txt	0	9	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	10	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	11	children	NNS	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	12	aged	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	13	6-7	CD	(NP*))))))	-	-	-	-	*	-
en_4138.txt	0	14	was	VBD	(VP*	-	-	-	-	*	-
en_4138.txt	0	15	also	RB	(ADVP*)	-	-	-	-	*	-
en_4138.txt	0	16	associated	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	17	with	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	18	an	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	19	increased	JJ	*	-	-	-	-	*	-
en_4138.txt	0	20	risk	NN	*)	-	-	-	-	*	-
en_4138.txt	0	21	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	22	symptoms	NNS	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	23	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	24	rhinitis	NN	(NP*	-	-	-	-	*	-
en_4138.txt	0	25	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	26	eczema	NN	*))))))))	-	-	-	-	*	-
en_4138.txt	0	27	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	This	DT	(TOP(S(NP*)	-	-	-	-	*	-
en_4138.txt	0	1	suggests	VBZ	(VP*	-	-	-	-	*	-
en_4138.txt	0	2	that	IN	(SBAR*	-	-	-	-	*	-
en_4138.txt	0	3	the	DT	(S(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	4	potential	JJ	*	-	-	-	-	*	-
en_4138.txt	0	5	effect	NN	*)	-	-	-	-	*	-
en_4138.txt	0	6	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	7	paracetamol	NN	(NP*)))	-	-	-	-	*	-
en_4138.txt	0	8	is	VBZ	(VP(VP*	-	-	-	-	*	-
en_4138.txt	0	9	not	RB	*	-	-	-	-	*	-
en_4138.txt	0	10	restricted	VBN	(ADJP*	-	-	-	-	*	-
en_4138.txt	0	11	to	TO	(PP*	-	-	-	-	*	-
en_4138.txt	0	12	the	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	13	airways	NNS	*))))	-	-	-	-	*	-
en_4138.txt	0	14	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	15	may	MD	(VP*	-	-	-	-	*	-
en_4138.txt	0	16	affect	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	17	a	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	18	number	NN	*)	-	-	-	-	*	-
en_4138.txt	0	19	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	20	organ	NN	(NP*	-	-	-	-	*	-
en_4138.txt	0	21	systems	NNS	*)))))))))	-	-	-	-	*	-
en_4138.txt	0	22	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	Identifying	VBG	(TOP(S(S(VP*	-	-	-	-	*	-
en_4138.txt	0	1	the	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	2	potential	JJ	*	-	-	-	-	*	-
en_4138.txt	0	3	mechanisms	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	4	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_4138.txt	0	5	might	MD	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	6	underlie	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	7	the	DT	(NP(NP*	-	-	-	-	*	(6
en_4138.txt	0	8	association	NN	*)	-	-	-	-	*	-
en_4138.txt	0	9	between	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	10	paracetamol	NN	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	11	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	12	asthma	NN	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	13	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_4138.txt	0	14	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	15	other	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	16	allergic	JJ	*	-	-	-	-	*	-
en_4138.txt	0	17	disorders	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	18	-RRB-	-RRB-	*))))))))))))	-	-	-	-	*	6)
en_4138.txt	0	19	was	VBD	(VP*	-	-	-	-	*	-
en_4138.txt	0	20	not	RB	*	-	-	-	-	*	-
en_4138.txt	0	21	a	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	22	part	NN	*)	-	-	-	-	*	-
en_4138.txt	0	23	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	24	this	DT	(NP*	-	-	-	-	*	(7
en_4138.txt	0	25	study	NN	*))))	-	-	-	-	*	7)
en_4138.txt	0	26	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	But	CC	(TOP(S(S(S*	-	-	-	-	*	-
en_4138.txt	0	1	other	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	2	researchers	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	3	have	VBP	(VP*	-	-	-	-	*	-
en_4138.txt	0	4	proposed	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	5	a	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	6	number	NN	*)	-	-	-	-	*	-
en_4138.txt	0	7	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	8	plausible	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	9	mechanisms	NNS	*))))))	-	-	-	-	*	-
en_4138.txt	0	10	,	,	*	-	-	-	-	*	-
en_4138.txt	0	11	primarily	RB	(S(ADVP*)	-	-	-	-	*	-
en_4138.txt	0	12	related	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	13	to	TO	(PP*	-	-	-	-	*	-
en_4138.txt	0	14	paracetamol	NN	(NP*))))	-	-	-	-	*	-
en_4138.txt	0	15	'	''	*	-	-	-	-	*	-
en_4138.txt	0	16	s	VBZ	(VP*	-	-	-	-	*	-
en_4138.txt	0	17	negative	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	18	effect	NN	*)	-	-	-	-	*	-
en_4138.txt	0	19	on	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	20	the	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	21	body	NN	*))))	-	-	-	-	*	-
en_4138.txt	0	22	'	:	*	-	-	-	-	*	-
en_4138.txt	0	23	s	VBZ	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	24	ability	NN	(NP*	-	-	-	-	*	-
en_4138.txt	0	25	to	TO	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	26	withstand	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	27	oxidant	JJ	(NP(NP*	-	-	-	-	*	(9
en_4138.txt	0	28	stress	NN	*)	-	-	-	-	*	9)
en_4138.txt	0	29	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	30	its	PRP$	(NP(NP*	-	-	-	-	*	(9)
en_4138.txt	0	31	potential	JJ	*	-	-	-	-	*	-
en_4138.txt	0	32	enhancement	NN	*)	-	-	-	-	*	-
en_4138.txt	0	33	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	34	the	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	35	allergic	JJ	*	-	-	-	-	*	-
en_4138.txt	0	36	immune	JJ	*	-	-	-	-	*	-
en_4138.txt	0	37	response	NN	*))))))))))	-	-	-	-	*	-
en_4138.txt	0	38	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	-
en_4138.txt	0	1	authors	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	2	emphasised	VBD	(VP*	-	-	-	-	*	-
en_4138.txt	0	3	that	IN	(SBAR*	-	-	-	-	*	-
en_4138.txt	0	4	causality	NN	(S(NP*)	-	-	-	-	*	-
en_4138.txt	0	5	could	MD	(VP*	-	-	-	-	*	-
en_4138.txt	0	6	not	RB	*	-	-	-	-	*	-
en_4138.txt	0	7	be	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	8	established	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	9	from	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	10	a	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	11	retrospective	JJ	*	-	-	-	-	*	-
en_4138.txt	0	12	study	NN	*)	-	-	-	-	*	-
en_4138.txt	0	13	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	14	this	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	15	design	NN	*))))	-	-	-	-	*	-
en_4138.txt	0	16	due	JJ	(PP*	-	-	-	-	*	-
en_4138.txt	0	17	to	TO	*	-	-	-	-	*	-
en_4138.txt	0	18	the	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	19	numerous	JJ	*	-	-	-	-	*	-
en_4138.txt	0	20	potential	JJ	*	-	-	-	-	*	-
en_4138.txt	0	21	biases	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	22	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_4138.txt	0	23	may	MD	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	24	confound	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	25	the	DT	(NP*	-	-	-	-	*	(6
en_4138.txt	0	26	association	NN	*)))))))))))))	-	-	-	-	*	6)
en_4138.txt	0	27	.	.	*	-	-	-	-	*	-
en_4138.txt	0	28	For	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	29	example	NN	(NP*))	-	-	-	-	*	-
en_4138.txt	0	30	,	,	*	-	-	-	-	*	-
en_4138.txt	0	31	it	PRP	(NP*)	-	-	-	-	*	(6)
en_4138.txt	0	32	is	VBZ	(VP*	-	-	-	-	*	-
en_4138.txt	0	33	known	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	34	that	IN	(SBAR(SBAR*	-	-	-	-	*	-
en_4138.txt	0	35	viral	JJ	(S(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	36	respiratory	NN	*	-	-	-	-	*	-
en_4138.txt	0	37	tract	NN	*	-	-	-	-	*	-
en_4138.txt	0	38	infections	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	39	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	40	infancy	NN	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	41	such	JJ	(PP*	-	-	-	-	*	-
en_4138.txt	0	42	as	IN	*	-	-	-	-	*	-
en_4138.txt	0	43	respiratory	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	44	syncytial	JJ	*	-	-	-	-	*	-
en_4138.txt	0	45	virus	NN	*))	-	-	-	-	*	-
en_4138.txt	0	46	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_4138.txt	0	47	RSV	NNP	(NP*)	-	-	-	-	*	-
en_4138.txt	0	48	-RRB-	-RRB-	*))))	-	-	-	-	*	-
en_4138.txt	0	49	are	VBP	(VP*	-	-	-	-	*	-
en_4138.txt	0	50	associated	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	51	with	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	52	an	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	53	increased	JJ	*	-	-	-	-	*	-
en_4138.txt	0	54	risk	NN	*)	-	-	-	-	*	-
en_4138.txt	0	55	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	56	asthma	NN	(NP*))	-	-	-	-	*	-
en_4138.txt	0	57	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	58	later	RB	(NP*	-	-	-	-	*	-
en_4138.txt	0	59	childhood	NN	*))))))))	-	-	-	-	*	-
en_4138.txt	0	60	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	61	that	IN	(SBAR*	-	-	-	-	*	-
en_4138.txt	0	62	paracetamol	JJ	(S(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	63	use	NN	*)	-	-	-	-	*	-
en_4138.txt	0	64	for	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	65	such	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	66	episodes	NNS	*)))	-	-	-	-	*	-
en_4138.txt	0	67	could	MD	(VP*	-	-	-	-	*	-
en_4138.txt	0	68	have	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	69	caused	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	70	confounding	VBG	(VP*	-	-	-	-	*	-
en_4138.txt	0	71	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	72	the	DT	(NP*	-	-	-	-	*	(7
en_4138.txt	0	73	study	NN	*)))))))))))	-	-	-	-	*	7)
en_4138.txt	0	74	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	(7
en_4138.txt	0	1	study	NN	*)	-	-	-	-	*	7)
en_4138.txt	0	2	has	VBZ	(VP*	-	-	-	-	*	-
en_4138.txt	0	3	contributed	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	4	to	TO	(PP*	-	-	-	-	*	-
en_4138.txt	0	5	the	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	6	debate	NN	*)	-	-	-	-	*	-
en_4138.txt	0	7	as	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	8	to	TO	(PP*	-	-	-	-	*	-
en_4138.txt	0	9	whether	IN	(SBAR*	-	-	-	-	*	-
en_4138.txt	0	10	it	PRP	(S(NP*)	-	-	-	-	*	(7)
en_4138.txt	0	11	is	VBZ	(VP*	-	-	-	-	*	-
en_4138.txt	0	12	beneficial	JJ	(ADJP*)	-	-	-	-	*	-
en_4138.txt	0	13	to	TO	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	14	treat	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	15	fever	NN	(NP(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	16	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	17	children	NNS	(NP*)))	-	-	-	-	*	-
en_4138.txt	0	18	,	,	*	-	-	-	-	*	-
en_4138.txt	0	19	an	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	20	issue	NN	*)	-	-	-	-	*	-
en_4138.txt	0	21	comprehensively	RB	(VP(ADVP*)	-	-	-	-	*	-
en_4138.txt	0	22	reviewed	VBN	*	-	-	-	-	*	-
en_4138.txt	0	23	by	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	24	Fiona	NNP	(NP(NP*	-	-	-	-	*	(10
en_4138.txt	0	25	Russell	NNP	*)	-	-	-	-	*	-
en_4138.txt	0	26	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	27	colleagues	NNS	(NP*))))))))))))))))	-	-	-	-	*	10)
en_4138.txt	0	28	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	29	the	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	30	Bulletin	NN	*)	-	-	-	-	*	-
en_4138.txt	0	31	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	32	the	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	33	World	NNP	*	-	-	-	-	*	-
en_4138.txt	0	34	Health	NNP	*	-	-	-	-	*	-
en_4138.txt	0	35	Organization	NNP	*))))))	-	-	-	-	*	-
en_4138.txt	0	36	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	They	PRP	(TOP(S(NP*)	-	-	-	-	*	(10)
en_4138.txt	0	1	propose	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	2	that	IN	(SBAR*	-	-	-	-	*	-
en_4138.txt	0	3	the	DT	(S(NP*	-	-	-	-	*	-
en_4138.txt	0	4	available	JJ	*	-	-	-	-	*	-
en_4138.txt	0	5	scientific	JJ	*	-	-	-	-	*	-
en_4138.txt	0	6	evidence	NN	*)	-	-	-	-	*	-
en_4138.txt	0	7	suggests	VBZ	(VP*	-	-	-	-	*	-
en_4138.txt	0	8	that	IN	(SBAR(SBAR*	-	-	-	-	*	-
en_4138.txt	0	9	fever	NN	(S(NP*)	-	-	-	-	*	(11)
en_4138.txt	0	10	is	VBZ	(VP*	-	-	-	-	*	-
en_4138.txt	0	11	a	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	12	universal	JJ	(ADJP(ADJP*)	-	-	-	-	*	-
en_4138.txt	0	13	,	,	*	-	-	-	-	*	-
en_4138.txt	0	14	ancient	JJ	(ADJP*)	-	-	-	-	*	-
en_4138.txt	0	15	,	,	*	-	-	-	-	*	-
en_4138.txt	0	16	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	17	usually	RB	(ADJP*	-	-	-	-	*	-
en_4138.txt	0	18	beneficial	JJ	*))	-	-	-	-	*	-
en_4138.txt	0	19	response	NN	*)	-	-	-	-	*	-
en_4138.txt	0	20	to	TO	(PP*	-	-	-	-	*	-
en_4138.txt	0	21	infection	NN	(NP*))))))	-	-	-	-	*	-
en_4138.txt	0	22	,	,	*	-	-	-	-	*	-
en_4138.txt	0	23	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	24	that	IN	(SBAR*	-	-	-	-	*	-
en_4138.txt	0	25	its	PRP$	(S(NP(NP*	-	-	-	-	*	(11)
en_4138.txt	0	26	suppression	NN	*)	-	-	-	-	*	-
en_4138.txt	0	27	under	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	28	most	JJS	(NP*	-	-	-	-	*	-
en_4138.txt	0	29	circumstances	NNS	*)))	-	-	-	-	*	-
en_4138.txt	0	30	has	VBZ	(VP*	-	-	-	-	*	-
en_4138.txt	0	31	few	JJ	(ADJP*	-	-	-	-	*	-
en_4138.txt	0	32	if	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	33	any	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	34	demonstrable	JJ	*	-	-	-	-	*	-
en_4138.txt	0	35	benefits	NNS	*)))))))))))	-	-	-	-	*	-
en_4138.txt	0	36	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	On	IN	(TOP(S(PP*	-	-	-	-	*	-
en_4138.txt	0	1	the	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	2	contrary	NN	*))	-	-	-	-	*	-
en_4138.txt	0	3	,	,	*	-	-	-	-	*	-
en_4138.txt	0	4	they	PRP	(NP*)	-	-	-	-	*	(10)
en_4138.txt	0	5	suggest	VBP	(VP*	-	-	-	-	*	-
en_4138.txt	0	6	that	IN	(SBAR*	-	-	-	-	*	-
en_4138.txt	0	7	suppressing	NN	(S(NP*	-	-	-	-	*	-
en_4138.txt	0	8	fever	NN	*)	-	-	-	-	*	-
en_4138.txt	0	9	may	MD	(VP(VP*	-	-	-	-	*	-
en_4138.txt	0	10	occasionally	RB	(ADVP*)	-	-	-	-	*	-
en_4138.txt	0	11	produce	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	12	harmful	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	13	effects	NNS	*)))	-	-	-	-	*	-
en_4138.txt	0	14	,	,	*	-	-	-	-	*	-
en_4138.txt	0	15	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	16	conclude	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	17	that	IN	(SBAR*	-	-	-	-	*	-
en_4138.txt	0	18	widespread	JJ	(S(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	19	use	NN	*)	-	-	-	-	*	-
en_4138.txt	0	20	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	21	drugs	NNS	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	22	to	TO	(SBAR(S(VP*	-	-	-	-	*	-
en_4138.txt	0	23	reduce	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	24	fever	NN	(NP*))))))))	-	-	-	-	*	-
en_4138.txt	0	25	should	MD	(VP*	-	-	-	-	*	-
en_4138.txt	0	26	not	RB	*	-	-	-	-	*	-
en_4138.txt	0	27	be	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	28	encouraged	VBN	(VP*))))))))))	-	-	-	-	*	-
en_4138.txt	0	29	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	They	PRP	(TOP(S(NP*)	-	-	-	-	*	(10)
en_4138.txt	0	1	recommend	VBP	(VP*	-	-	-	-	*	-
en_4138.txt	0	2	that	IN	(SBAR*	-	-	-	-	*	-
en_4138.txt	0	3	in	IN	(S(PP*	-	-	-	-	*	-
en_4138.txt	0	4	children	NNS	(NP*))	-	-	-	-	*	-
en_4138.txt	0	5	their	PRP$	(NP*	-	-	-	-	*	(10)
en_4138.txt	0	6	use	NN	*)	-	-	-	-	*	-
en_4138.txt	0	7	should	MD	(VP*	-	-	-	-	*	-
en_4138.txt	0	8	be	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	9	restricted	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	10	to	TO	(PP*	-	-	-	-	*	-
en_4138.txt	0	11	situations	NNS	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	12	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	13	high	JJ	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	14	fever	NN	*)	-	-	-	-	*	-
en_4138.txt	0	15	,	,	*	-	-	-	-	*	-
en_4138.txt	0	16	obvious	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	17	discomfort	NN	*)	-	-	-	-	*	-
en_4138.txt	0	18	,	,	*	-	-	-	-	*	-
en_4138.txt	0	19	or	CC	*	-	-	-	-	*	-
en_4138.txt	0	20	conditions	NNS	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	21	known	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	22	to	TO	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	23	be	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	24	painful	JJ	(ADJP*))))))))))))))))	-	-	-	-	*	-
en_4138.txt	0	25	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	What	WP	(TOP(S(SBAR(WHNP*)	-	-	-	-	*	-
en_4138.txt	0	1	is	VBZ	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	2	agreed	VBN	(VP*))))	-	-	-	-	*	-
en_4138.txt	0	3	is	VBZ	(VP*	-	-	-	-	*	-
en_4138.txt	0	4	the	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	5	need	NN	*)	-	-	-	-	*	-
en_4138.txt	0	6	for	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	7	randomized	JJ	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	8	controlled	JJ	*	-	-	-	-	*	-
en_4138.txt	0	9	trials	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	10	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	11	the	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	12	long-term	JJ	*	-	-	-	-	*	-
en_4138.txt	0	13	effects	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	14	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	15	repeated	VBN	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	16	use	NN	*)	-	-	-	-	*	-
en_4138.txt	0	17	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	18	paracetamol	NN	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	19	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	20	children	NNS	(NP*))))))))))))	-	-	-	-	*	-
en_4138.txt	0	21	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	Only	RB	(TOP(SINV(ADVP*	-	-	-	-	*	-
en_4138.txt	0	1	then	RB	*)	-	-	-	-	*	-
en_4138.txt	0	2	will	MD	*	-	-	-	-	*	-
en_4138.txt	0	3	it	PRP	(NP*)	-	-	-	-	*	(12)
en_4138.txt	0	4	be	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	5	possible	JJ	(ADJP*	-	-	-	-	*	-
en_4138.txt	0	6	to	TO	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	7	develop	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	8	evidence-based	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	9	guidelines	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	10	for	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	11	its	PRP$	(NP*	-	-	-	-	*	(12)
en_4138.txt	0	12	recommended	VBN	*	-	-	-	-	*	-
en_4138.txt	0	13	use	NN	*)))))))	-	-	-	-	*	-
en_4138.txt	0	14	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	Pending	VBG	(TOP(S(S(VP*	-	-	-	-	*	-
en_4138.txt	0	1	the	DT	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	2	results	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	3	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	4	such	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	5	research	NN	*)))))	-	-	-	-	*	-
en_4138.txt	0	6	,	,	*	-	-	-	-	*	-
en_4138.txt	0	7	paracetamol	NN	(NP*)	-	-	-	-	*	-
en_4138.txt	0	8	remains	VBZ	(VP*	-	-	-	-	*	-
en_4138.txt	0	9	the	DT	(NP(NP*	-	-	-	-	*	(13
en_4138.txt	0	10	preferred	VBN	*	-	-	-	-	*	-
en_4138.txt	0	11	drug	NN	*)	-	-	-	-	*	-
en_4138.txt	0	12	to	TO	(SBAR(S(VP*	-	-	-	-	*	-
en_4138.txt	0	13	relieve	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	14	pain	NN	(NP*	-	-	-	-	*	-
en_4138.txt	0	15	and	CC	*	-	-	-	-	*	-
en_4138.txt	0	16	fever	NN	*)	-	-	-	-	*	-
en_4138.txt	0	17	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	18	childhood	NN	(NP*))	-	-	-	-	*	-
en_4138.txt	0	19	,	,	*	-	-	-	-	*	-
en_4138.txt	0	20	to	TO	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	21	be	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	22	used	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	23	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	24	accordance	NN	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	25	with	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	26	WHO	JJ	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	27	guidelines	NNS	*)	-	-	-	-	*	-
en_4138.txt	0	28	,	,	*	-	-	-	-	*	-
en_4138.txt	0	29	which	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_4138.txt	0	30	recommend	VBP	(S(VP(VP*	-	-	-	-	*	-
en_4138.txt	0	31	that	IN	(SBAR*	-	-	-	-	*	-
en_4138.txt	0	32	it	PRP	(S(NP*)	-	-	-	-	*	(12)
en_4138.txt	0	33	should	MD	(VP*	-	-	-	-	*	-
en_4138.txt	0	34	be	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	35	reserved	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	36	for	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	37	children	NNS	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	38	with	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	39	a	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	40	high	JJ	*	-	-	-	-	*	-
en_4138.txt	0	41	fever	NN	*))))))))))	-	-	-	-	*	-
en_4138.txt	0	42	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_4138.txt	0	43	38.5Co	JJ	(ADJP*	-	-	-	-	*	-
en_4138.txt	0	44	or	CC	*	-	-	-	-	*	-
en_4138.txt	0	45	above	JJ	*)	-	-	-	-	*	-
en_4138.txt	0	46	-RRB-	-RRB-	*))))))))))))))))))	-	-	-	-	*	13)
en_4138.txt	0	47	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	1	use	NN	*)	-	-	-	-	*	-
en_4138.txt	0	2	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	3	aspirin	NN	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	4	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	5	young	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	6	children	NNS	*)))))	-	-	-	-	*	-
en_4138.txt	0	7	is	VBZ	(VP*	-	-	-	-	*	-
en_4138.txt	0	8	contraindicated	VBN	(VP*	-	-	-	-	*	-
en_4138.txt	0	9	,	,	*	-	-	-	-	*	-
en_4138.txt	0	10	owing	VBG	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	11	to	TO	(PP*	-	-	-	-	*	-
en_4138.txt	0	12	the	DT	(NP(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	13	risk	NN	*)	-	-	-	-	*	-
en_4138.txt	0	14	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	15	Reye	NNP	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	16	'	POS	*)	-	-	-	-	*	-
en_4138.txt	0	17	s	JJ	*	-	-	-	-	*	-
en_4138.txt	0	18	syndrome	NN	*)))	-	-	-	-	*	-
en_4138.txt	0	19	,	,	*	-	-	-	-	*	-
en_4138.txt	0	20	a	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	21	rare	JJ	(ADJP*	-	-	-	-	*	-
en_4138.txt	0	22	but	CC	*	-	-	-	-	*	-
en_4138.txt	0	23	serious	JJ	*)	-	-	-	-	*	-
en_4138.txt	0	24	complication	NN	*)))))))	-	-	-	-	*	-
en_4138.txt	0	25	.	.	*))	-	-	-	-	*	-

en_4138.txt	0	0	Paracetamol	NNP	(TOP(S(NP*)	-	-	-	-	*	(0)
en_4138.txt	0	1	also	RB	(ADVP*)	-	-	-	-	*	-
en_4138.txt	0	2	remains	VBZ	(VP*	-	-	-	-	*	-
en_4138.txt	0	3	the	DT	(NP*	-	-	-	-	*	(13
en_4138.txt	0	4	preferred	VBN	*	-	-	-	-	*	-
en_4138.txt	0	5	drug	NN	*)	-	-	-	-	*	13)
en_4138.txt	0	6	to	TO	(S(VP*	-	-	-	-	*	-
en_4138.txt	0	7	relieve	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	8	pain	NN	(NP(NP*	-	-	-	-	*	-
en_4138.txt	0	9	or	CC	*	-	-	-	-	*	-
en_4138.txt	0	10	fever	NN	*)	-	-	-	-	*	-
en_4138.txt	0	11	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	12	children	NNS	(NP*	-	-	-	-	*	-
en_4138.txt	0	13	or	CC	*	-	-	-	-	*	-
en_4138.txt	0	14	adults	NNS	*)))	-	-	-	-	*	-
en_4138.txt	0	15	with	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	16	asthma	NN	(NP*)))))	-	-	-	-	*	-
en_4138.txt	0	17	,	,	*	-	-	-	-	*	-
en_4138.txt	0	18	because	IN	(SBAR*	-	-	-	-	*	-
en_4138.txt	0	19	aspirin	NN	(S(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	20	or	CC	*	-	-	-	-	*	-
en_4138.txt	0	21	other	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	22	non-steroidal	JJ	*	-	-	-	-	*	-
en_4138.txt	0	23	anti-inflammatory	JJ	*	-	-	-	-	*	-
en_4138.txt	0	24	drugs	NNS	*))	-	-	-	-	*	-
en_4138.txt	0	25	may	MD	(VP*	-	-	-	-	*	-
en_4138.txt	0	26	provoke	VB	(VP*	-	-	-	-	*	-
en_4138.txt	0	27	attacks	NNS	(NP(NP*)	-	-	-	-	*	-
en_4138.txt	0	28	of	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	29	asthma	NN	(NP*)))	-	-	-	-	*	-
en_4138.txt	0	30	in	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	31	susceptible	JJ	(NP*	-	-	-	-	*	-
en_4138.txt	0	32	people	NNS	*))	-	-	-	-	*	-
en_4138.txt	0	33	with	IN	(PP*	-	-	-	-	*	-
en_4138.txt	0	34	this	DT	(NP*	-	-	-	-	*	-
en_4138.txt	0	35	condition	NN	*)))))))	-	-	-	-	*	-
en_4138.txt	0	36	.	.	*))	-	-	-	-	*	-

#end document
